Revalesio to Present Research on the Anti-Inflammatory Effects of RNS60 in Asthma – Genetic Engineering News

Revalesio to Present Research on the Anti-Inflammatory Effects of RNS60 in Asthma
Genetic Engineering News
Revalesio Corporation announced today that research related to the use of RNS60, its novel anti-inflammatory, will be featured in two poster presentations at the Annual Meeting of the American Academy of Allergy Asthma and Immunology (AAAAI) in San

and more »

View full post on asthma – Google News

Forest Labs, Allergy Asthma Research Institute sign up with SAFE-BioPharma … – Pharmaceutical Business Review

Forest Labs, Allergy Asthma Research Institute sign up with SAFE-BioPharma
Pharmaceutical Business Review
Forest Laboratories and Allergy Asthma Research Institute have joined SAFE-BioPharma Association to have access to the SAFE-BioPharma digital identity and signature standard for the verification and management of digital identities involved in
Forest Laboratories and Allergy Asthma Research Institute Join SAFE-BioPharma PharmiWeb.com (press release)

all 2 news articles »

View full post on asthma – Google News